BioAtla

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.

CEO

Jay M. Short

CEOJay M. Short

Employees

Employees76

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

Employees76

BCAB Key Statistics

Market cap

20.58M

Market cap20.58M

Price-Earnings ratio

-0.30

Price-Earnings ratio-0.30

Dividend yield

—

Dividend yield—

Average volume

762.78K

Average volume762.78K

High today

$0.3863

High today$0.3863

Low today

$0.35

Low today$0.35

Open price

$0.3651

Open price$0.3651

Volume

1.39M

Volume1.39M

52 Week high

$2.53

52 Week high$2.53

52 Week low

$0.24

52 Week low$0.24

People also own

Based on the portfolios of people who own BCAB. This list is generated using Robinhood data, and it’s not a recommendation.